Veterinary and Comparative Oncology

Curative-intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: a preliminary retrospective evaluation of 14 dogs with the disease
pp. 1-7(7)
Authors: Walter C. U.; Dernell W. S.; LaRue S. M.; Lana S. E.; Lafferty M. H.; LaDue T. A.; Withrow S. J.

Immunohistochemical detection of HER-2/neu expression in spontaneous feline mammary tumours
pp. 8-15(8)
Authors: Winston J.; Craft D. M.; Scase T. J.; Bergman P. J.

Piroxicam and carboplatin as a combination treatment of canine oral non-tonsillar squamous cell carcinoma: a pilot study and a literature review of a canine model of human head and neck squamous cell carcinoma
pp. 16-24(9)
Authors: de Vos J. P.; Burm A. G. D.; Focker A. P.; Boschloo H.; Karsijns M.; van der Waal I.

Canine PHA-stimulated adherent cell enhance interferon-gamma production and proliferation of autologous peripheral blood mononuclear cells
pp. 25-31(7)
Authors: Ide Kaori; Momoi Yasuyuki; Iwasaki Toshiroh

Abstracts presented at the Veterinary Cancer Society Annual Conference Kansas City, Missouri, 3–6^th November 2004: As the official journal of the Veterinary Cancer Society, Veterinary and Comparative Oncology is pleased to include these abstracts from the Annual Conference and we hope you find them informative and useful. These abstracts have not been subjected to peer review or editorial revision, however, and it would be prudent for the reader to exercise caution in the interpretation and application of the data presented.
pp. 32-32(1)

Total Skin Electron Beam Irradiation for Generalized Cutaneous Lymphoma
pp. 32-32(1)
Authors: Prescott D. M.; Gordon J.

Comparative Oncology Solution to Understanding Hormonal Impact in the Epidemiology of Lymphoma
pp. 33-33(1)
Authors: Henry C. J.; Hahn A. W.; Tyler J. W.; Steinberg H. S.; Caldwell C. W.

Targeting the RNA component of Telomerase Through RNA Interference and the Development of Vector Delivery Systems
pp. 33-34(2)
Authors: Paoloni M.; Gunderman J. R.; Estelle L. N.; Padilla M.; Argyle D. J.

Immunohistochemical Differentiation and Clinicopathological Features of Canine Gastrointestinal Stromal Tumors and Leiomyosarcomas
pp. 34-34(1)
Authors: Russell K. N.; Mehler S. J.; Skorupski K. A.; Baez J. L.; Shofer F. S.; Goldschmidt M. H.

Effects of Mycobacterial Cell Wall-DNA Complex (MCC), Alendronate and Pamidronate on Canine Osteosarcoma Cell Lines
pp. 35-35(1)
Authors: Filion M. C.; Filion B.; Phillips N. C.

Phase I & Ib Trials of Murine Tyrosinase ± Human GM-CSF DNA Vaccination in Dogs with Advanced Malignant Melanoma
pp. 35-36(2)
Authors: Bergman P. J.; Camps-Palau M. A.; McKnight J. A.; Leibman N. F.; Novosad C. A.; Brenn S.; Ettinger S. N.; Endicott M. M.; Finora K.; Craft D.; Leung C.; Liao J.; Riviere I.; Hohenhaus A. E.; Houghton A.; Perales M.; Wolchok J. D.

Retropective Evaluation of Survival Time of Dogs with Stage III Osteosarcoma that Undergo Treatment
pp. 36-37(2)
Authors: Boston S.; Ehrhart N.; Dernell W.; Lafferty M.; Withrow S.

Long-Term Totally Implantable Venous Access Ports in Dogs and Cats Receiving Chemotherapy
pp. 37-37(1)
Authors: Bryson V.; Fox L. E.; Crum H.

Magnetic resonance imaging characterization of canine splenic lesions
pp. 37-38(2)
Authors: Clifford C. A.; Pretorius E. S.; Weisse C.; Siegelman E. S.; Sorenmo K. U.; Skorupski K.; Drobatz K.; Burgess K. E.; Fred R. M.; Glass E. N.; Murray M.; Solomon J. R.

Coarse Fractionated Radiation Therapy for Pituitary Tumours in Cats: A Retrospective Study of 10 Cases
pp. 38-39(2)
Authors: Brearley M. J.; Polton G. A.

Feline Sinonasal Neoplasia: CT Staging and Prognosis with Mega Voltage Radiation Therapy
pp. 39-39(1)
Authors: de Lorimier L. P.; Fan T. M.; Haney S.; Grimm J. B.; Charney S. C.; Clifford C. A.

Prostatic Neoplasia: In Search of a Treatment
pp. 39-40(2)
Authors: Henderson R. A.; Smith A. N.; Higginbotham M. L.

The Utility of PCR for Antigen Receptor Rearrangement (PARR) in Staging and Predicting Prognosis in Canine Lymphoma
pp. 40-41(2)
Authors: Lana S. E.; Jackson T. L.; Burnett R. C.; Morley P.; Avery A. C.

Increase in Regulatory T Cells in Dogs with Cancer Undergoing Chemotherapy
pp. 41-41(1)
Authors: Biller B. J.; Walter C. U.; Lana S. E.; Dow S. W.

Association of p53 Gene Mutation with the Prognosis of Canine Lymphoid Tumors
pp. 42-42(1)
Authors: Koshino A.; Setoguchi A.; Ohno K.; Tsujimoto H.

Results of the Combined Treatment with Piroxicam and Carboplatin in Canine Oral Non-Tonsillar Squamous Cell Carcinoma
pp. 42-43(2)
Authors: de Vos J. P.; Burm A. G. D.; Focker B. P.; Boschloo H.; Karsijns M.

Evaluation of Intracavitary Chemotherapy Delivery for the Treatment of Mammary Carcinoma
pp. 43-43(1)
Authors: De Lille A.; Rizzo S. A.; Hudacheck S. F.; Chubb L. S.; Kwong G.; Dernell W. S.

Proteins Involved in Glucose Recognition and Signaling are Expressed by Canine Insulinoma
pp. 44-44(1)
Authors: Donley V.; Hiskett E.; Schermerhorn T.

COX-2 Expression in Feline Oral Squamous Cell Carcinoma (FOSCC)– An Immunohistochemical Study and Analysis of Survival
pp. 44-45(2)
Authors: Hayes A.; Scase T.; Miller J.; Murphy S; Sparkes A.; Adams V.

Anti-Tumor Effect of Adenovirus-Mediated P53 Gene Therapy on the Growth of Canine Osteosarcoma Transplanted into Nude Mice
pp. 45-46(2)
Authors: Kanaya N.; Yazawa M.; Mochizuki M.; Nishimura R.; Sasaki N.; Setoguchi A.; Ohno K.; Tsujimoto H.

Histological Subtypes of Canine Lymphoma are Characterized by Unique Gene Expression Profiles
pp. 46-46(1)
Authors: Kisseberth W. C.; Kosarek C. E.; Auer H.; Kornacker K.; Valli V. E.; Couto C. G.

Antitumor Activity of Mycobacterial Cell Wall-DNA Complex (MCC) Against Canine Urinary Bladder Transitional Cell Carcinoma Cells
pp. 46-47(2)
Authors: Knapp D. W.; Filion B.; Filion M. C.; Phillips N. C.

Efficacy of C/B-OPP rescue for the treatment of relapsed canine lymphoma (1998–2004)
pp. 47-48(2)
Authors: LeBlanc A. K.; Mauldin G. E.; Milner R. J.; Cooke K. L.; LaDue T. A.; Mauldin G. N.

Xenogeneic Human Tyrosinase DNA Vaccination Induces Specific Immune Response in Dogs with Advanced Malignant Melanoma
pp. 48-48(1)
Authors: Liao J.; Gregor P.; Orlandi F.; Craft D. M.; Leung C.; Houghton A. N.; Wolchok J. D.; Bergman P. J.

Characterization, Expression and Function of c-MET in Canine Spontaneous Cancers
pp. 49-49(1)
Authors: Liao A. T.; McMahon M.; London C. A.

A Candidate Second-Generation Photosensitizer for Photodynamic Therapy in Veterinary Medicine
pp. 49-50(2)
Authors: Borgatti-Jeffreys A.; Hooser S. B.; Miller M. A.; Thomas R. M.; deGortari A.; Lucroy M. D.

Induction of Chemoresistance by Transfection of the Full-Length Canine mdr1 Gene in Canine Cell Lines
pp. 50-50(1)
Authors: Matsuura S.; Koto H.; Koshino A.; Okayama T.; Setoguchi A.; Ohno K.; Tsujimoto H.

The Biologic Behavior of Mast Cell Tumors in Pug Dogs
pp. 51-51(1)
Authors: Prink A. L.; McNiel E. A.; O'Brien T. D.

Characterization of the Biological Behavior of Appendicular Osteosarcoma in Rottweilers with a Comparison to Other Breeds
pp. 51-52(2)
Authors: McNeill C. J.; Clifford C. A.; Shofer F. S.; Samluk M. R.; Van Winkle T. J.; Sorenmo K. U.

¹³¹-I therapy for Advanced, Unresectable Thyroid Tumors in Dogs
pp. 52-53(2)
Authors: Turrel J.; Burke B.; Ullman S.; McEntee M.; Page R.

The Utility of Flow Cytometry for the Diagnosis of Cranial Mediastinal Malignancy in Canine Patients
pp. 53-53(1)
Authors: Plaza S. S.; Avery A. C.; Lana S. E.

Expression of E-cadherin in Canine Anal Sac Apocrine Gland Adenocarcinoma and its Association with Survival
pp. 53-54(2)
Authors: Polton G. A.; Adams V.; Green L. M.; Brearley M. J.; Scase T. J.

The effect of deracoxib and piroxicam on viability of canine osteosarcoma cells in vitro
pp. 54-55(2)
Authors: Royals S.; Farese J.; Milner R.; Lee-Ambrose L.

Serum and Plasma Vascular Endothelial Growth Factor Levels in Various Cat Populations
pp. 55-55(1)
Authors: Smith Annette N.; Vaughn J. A.; Whatley M.; Truett A.; Keen J.

Efficacy and Toxicity of Intracavitary Administration of Pegylated Liposomal Encapsulated Doxorubicin (DOXIL) in Dogs with Hemangiosarcoma
pp. 55-56(2)
Authors: Sorenmo Karin; Samluk Marissa; Clifford Craig; Baez Jennifer; Overley Beth; Skorupski Katherine; Oberthaler Karen; Barrett Jeffrey; Winkle Tom Van; Seiler Gabriela; Poppenga Robert; Shofer Frances

Cyclooxygenase -2 Expression in Mammary Tumors in Dogs and its Correlation to Histologic and Biologic Behavior
pp. 56-57(2)
Authors: De Nardi A. B.; Daleck C. R.; Souza C. H. M.; Amorin R. L.; Rodaski S.; Calderon C.; Torres R.

Identification of a Splice Variant of gp100 Expressed in Canine Melanoma Tumours
pp. 57-57(1)
Authors: Stell A.; Dobson J.; Catchpole B.

RT-PCR based Tyrosine Kinase Display Profiling of Canine Melanoma: IGF-1 Receptor as a Potential Therapeutic Target
pp. 57-58(2)
Authors: Huelsmeyer M. K.; Mitzey A.; Baker T.; Swaab M.; Thamm D. H.

Evaluation of Liposomal Radiochemotherapy for Treatment of Cancer
pp. 58-59(2)
Authors: Jonasdottir T. J.; Borrebæk J.; Bruland ØS; Salberg G.; Moe L.; Larsen R. H.

An hGM-CSF DNA-Cationic Lipid Complexed Autologous Tumor Cell Vaccine did not Improve Remission Duration in Dogs with Lymphoma
pp. 59-59(1)
Authors: Turek M. M.; Thamm D. H.; Mitzey A. M.; Kurzman I. D.; Huelsmeyer M. K.; Dubielzig R. R.; Vail D. M.

Review of BSAVA Manual of Canine and Feline Oncology, 2nd Edition
pp. 60-60(1)
Authors: Langova V.; Straw R.